Tap into a Global Network of Leading CNS Drug Developers, Forge Strategic Partnerships & Propel Your Business Forward
With the neuropsychiatry field experiencing a turbulent mix of breakthroughs and high‑profile clinical setbacks, pharma and biotech remain deeply committed to advancing next‑generation mental health therapeutics. Investment continues to surge across neuroplastogens, muscarinic programs, and psychedelics, highlighted by MapLight’s $250M IPO, AbbVie’s $1.2B deal with Gilgamesh, and Minerva’s $200M financing, demonstrating strong confidence in mechanisms with robust biological rationale and long‑term potential.
Despite this momentum, progress remains hindered by persistent barriers spanning placebo response, heterogeneous patient populations, endpoint subjectivity, trial execution challenges, and regulatory uncertainty. The 9th Neuropsychiatric Drug Development Summit brings together 150+ senior leaders, innovators, and scientists actively seeking solutions to overcome these roadblocks and advance truly transformative psychiatric treatments.
Are you looking to elevate your commitment to the neuropsychiatry community and help drive meaningful progress for patients?
Network with Decision‑Makers Driving Neuropsychiatric Innovation
Accelerate high‑value connections through curated networking formats and targeted 1‑to‑1 meetings. Build meaningful relationships with senior leaders across pharma, biotech, academia, and service providers shaping the future of neuropsychiatric drug development
Position Yourself at the Forefront of a Rapidly Evolving Field
Stay ahead of shifting scientific, clinical, and regulatory realities in neuropsychiatry. Learn from the latest advances in novel mechanisms, biomarkers, endpoints, and trial design strategies across CNS and mental health indications
Differentiate Your Capabilities & Become a Partner of Choice
Showcase your unique expertise and services to stand out as a strategic partner for neuropsychiatric drug developers. Demonstrate impact across discovery, translational science, clinical development, and data generation to support the next wave of CNS innovation
Key Services & Solutions
What Types of Companies Can Benefit Most from a Partnership with the 9th Neuropsychiatric Drug Development Summit?
- EEG services: Enhanced Tools for Generating & Analyzing Good Quality EEG Data
- Preclinical Assays that can Predictively Model Human-Relevant Psychiatric Disease Phenotypes
- Biomarker Tools Navigating Mood Disorder Heterogeneity with State of the Art Technologies to Detect Specific Symptoms Earlier
- Digital biomarkers & Clinical Measures as Reliable Monitoring Technologies to Objectively Measure Mood & Behavioural Symptoms
- Clinical CROs offering support with Placebo-Controlled Studies to Generate High-Quality Clinical Data & Streamline Site Selection & Recruitment
Recognize yourself and your business priorities in this description? With speaking and exhibitor inventory already running low, don’t hesitate to reach out for more information on partnership packages, attendee lists and create a bespoke package that aligns with your goals together.
Or click here to explore who’s already partnered for 2026 …
Hear What Our Past Sponsors Have to Say
The mix of attendees and the EEG focus day were excellent
Associate Director, Transpharmation™
I loved the staff and format; it was great to see what is in the pipeline, and the opportunity to meet 1:1 for great networking opportunities. I appreciated the content, community and collaborative culture, and will be back!
Business Development Manager, Aqualane Clinical Research
The range of expertise in the audience and diversity of topics provided a great environment to learn
Manager, Business Development, Alkermes
Strong science, excellent line up of long-standing psychiatry sponsors as well as attracted a lot of new companies/biotechs which was really nice to see and learn about
VP Business Development, Evolution Research Group
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Hannah Martin
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.